NCT00726167

Serum Procalcitonin Study in the Management of Ventilated Patients

Clinical Utility of Serum Procalcitonin in the Management of Ventilator-Associated Pneumonia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 29 (actual)
• Sponsor: University of Missouri-Columbia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.

Detailed description

Ventilator-associated pneumonia is a leading cause of mortality in critically ill patients. The purpose of this study is to evaluate the relationship between the onset/progress/resolution of pneumonia and the levels of Procalcitonin, a prohormone whose concentrations fluctuate in response to bacterial infection.

Conditions

• Ventilator Associated Pneumonia

Interventions

Type	Name	Description
DEVICE	Procalcitonin Level	Procalcitonin concentrations will be determined every day and will be compared with the clinical diagnosis based upon standard clinical practice. All subjects enrolled will be followed until the patient is either extubated or discharged from the SICU.

Timeline

• Start date: 2008-09-01
• Primary completion: 2014-08-01
• Completion: 2014-08-01
• First posted: 2008-07-31
• Last updated: 2016-10-05

Locations

1 site across 1 country: United States